ST 1535
Product Specifications
UNSPSC Description
ST 1535 is a potent and orally active A2A adenosine receptor antagonist. ST 1535 shows antiparkinsonian activity and antitremorigenic effects. ST 1535 has the potential for the research of Parkinson’s disease[1][2].
Target Antigen
Adenosine Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/st-1535.html
Purity
99.80
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
CN1C(N2N=CC=N2)=NC3=C1N=C(CCCC)N=C3N
Molecular Weight
272.31
References & Citations
[1]Stasi MA, et al. ST 1535: a preferential A2A adenosine receptor antagonist. Int J Neuropsychopharmacol. 2006 Oct;9(5):575-84.|[2]Tronci E, et al. Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats. Eur J Pharmacol. 2007 Jul 2;566(1-3):94-102.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-105003/ST-1535-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-105003/ST-1535-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
496955-42-1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items